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Abstract: Pain control in fibromyalgia patients is limited no matter the therapeutic regimens used. Recent data have 
shown that daily sessions of anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) in 
patients with fibromyalgia (FM) are associated with reduction of pain perception. 
Objective: We aimed to test whether active tDCS, as compared with sham tDCS, combined with multidisciplinary 
rehabilitation is associated with significant clinical gains in fibromyalgia. 
Design: This was a randomized, double-blinded controlled trial. 
Subjects: 23 patients were randomized to receive weekly sessions of multidisciplinary rehabilitation approach combined 
with sham or anodal tDCS of M1. Patients were evaluated for pain with VAS and for quality of life with SF-36, 
fibromyalgia pain questionnaire and health assessment questionnaire by a blinded rater before and after the 4 month 
period of rehabilitation. 
Results: Patients tolerated tDCS treatment well, without adverse effects. Patients who received active treatment had a 
significantly greater reduction of SF-36 pain domain scores (F(2,21)=6.57; p=0.006) and a tendency of higher improvement 
in Fibromyalgia Impact Questionnaire (FIQ) scores after (p=0.056) as compared with sham tDCS/standard treatment, but 
no differences were observed in the other domains. 
Conclusions: Although active tDCS was associated with superior results in one domain (SF-36 pain domain), the lack of 
significance in the other domains does not fully support this strategy (weekly tDCS) combined with a multidisciplinary 
approach. 
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INTRODUCTION 
  Fibromyalgia is characterized by chronic widespread 
pain, mainly on musculoskeletal structures, and multiple 
additional clinical manifestations [1]. The most accepted 
pathophysiologic model considers imbalance between 
nociception and normal physiologic pain control [2]. 
According to this model, there is an overall decrease in the 
inhibitory pain-related pathways; allowing, thus, low 
intensity or non-nociceptive stimuli to be processed in pre-
cortical and cortical pain-related structures involved in the 
affective and cognitive processing of pain [3]. The net result 
is an increase in pain perception. Based on this theory, 
therapeutic approaches aiming at the modulation of central 
nervous system might be beneficial. In fact the development 
of techniques of non-invasive brain stimulation has provided  
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a means for such modulation. One technique that has been 
studied for the treatment of chronic pain is transcranial direct 
current stimulation (tDCS) [4-12]. 
  In transcranial direct current stimulation (tDCS), a pair of 
electrodes is placed on the scalp and low intensity 
continuous current flows between them [4]. Depending on 
the electrodes location, it has been shown that this technique 
induces significant currents in cortical areas that induce 
significant changes in cortical excitability [6]. Several 
human studies have shown that tDCS induces changes in 
cortical excitability depending on the current orientation; 
such as that anodal stimulation increases cortical excitability 
and cathodal stimulation decreases it [5,13]. These 
excitability changes can be explained by synaptic changes 
and direct effects on neuronal spontaneous activity [7]. 
  Based on the noninvasive and safe profile of this 
technique; several studies have been conducted testing the 
efficacy of tDCS for the treatment of chronic pain including 
pain in spinal cord injury [8] and fibromyalgia [9,14]. In 
fact, in a previous study, Fregni et al. [9] showed that 20 
minutes of daily direct anodal stimulation over the primary 46   The Open Rheumatology Journal, 2011, Volume 5  Riberto et al. 
motor cortex for 5 days is effective to decrease pain in 
patients with fibromyalgia as compared with sham and to 
active prefrontal tDCS. Because the mechanisms of action of 
tDCS that induces a change in neuronal spontaneous activity; 
the use of this technique coupled with behavioral 
interventions might enhance its effect as demonstrated 
before in motor learning [10], speech therapy [11]  and 
working memory [15]. Therefore we hypothesized that 
fibromyalgic subjects under in a rehabilitation program for 
pain would achieve greater benefit as indexed by pain and 
quality of life scales if they were submitted to anodal tDCS 
of M1 rather than sham stimulation, active tDCS of M1 
coupled with a rehabilitation program for pain would result 
in a greater benefit as indexed by pain and quality of life 
scales as compared with sham tDCS coupled with the same 
rehabilitation program. 
MATERIALS AND METHODOLOGY 
Study Design and Participants 
  We performed a randomized, double blind, single-center 
placebo controlled trial. This study has been approved by the 
local ethics committee, in accordance with the Helsinki 
declaration, and all the subjects signed a written informed 
consent form. 
  Our inclusion criteria were: 1) females who fulfilled the 
American College of Rheumatology criteria for 
fibromyalgia, because fibromyalgia is much more prevalent 
in women, the restrict male participation was based on 
convenience; 2) Aged from 18 to 65 years old; 3) Able to 
participate in the rehabilitation program for fibromyalgia. 
We excluded patients with psychiatric and behavioral 
conditions severe enough to limit the participation in group 
activities and those with other restrictive health conditions. 
Finally patients with cardiovascular limitation for exercise 
were also excluded, because treatment is mostly based on 
cardiovascular training. 
  Sample size calculation was based on the assumption of 
significance of 0.05 and power of 0.80. According the Fregni 
results [9], a mean reduction of 3 points in VAS for the 
group under active stimulation was expected, in contrast to 
no improvement in the sham group. This resulted in 2 groups 
with 10 participants. We decided to add 2 more patients in 
each group in order to prevent any reduction of power in 
case of patient desistence. Finally, we enrolled 23 patients to 
participate in the study (Table 1 describes demographic 
characteristics). They underwent the same multidisciplinary 
rehabilitation program for pain and were randomly assigned 
to active tDCS (A) or sham (S) using a simple randomization 
method. 
Rehabilitation Program for Pain 
  All subjects participated in the same rehabilitation 
program for pain, which has lasts 4 months and is comprised 
by the following routine: during the first hour subjects have 
educative interventions or cognitive behavior group therapy 
focused in pain. Subjects are oriented on posture and 
ergonomics by physical and occupational therapists and in 
behavioral modulation by psychologists and social workers, 
and during the second hour they participate in cardiovascular 
and strengthening training or stretching exercises. Subjects 
have these sessions 3 times a week. This program is the 
standard treatment in our clinic at University of Sao Paulo as 
has shown before to be effective [16]. 
Transcranial Direct Current Stimulation 
  Direct current was transferred by a saline-soaked pair of 
surface sponge electrodes (35cm
2) and delivered by a 
specially developed, battery-driven, constant current 
stimulator. Patients were randomized to two different types 
of treatment: 
1)  Anodal stimulation of primary motor cortex (M1) - 
the anode electrode was placed over C3 (EEG 10/20 
system) and the cathode electrode over the 
contralateral supraorbital area – similar to the 
montage of the study of Fregni et al. [8,14]. 
2)  Sham stimulation of M1 - For sham stimulation, the 
electrodes were placed in the same positions as for 
anodal M1 stimulation; however, the stimulator was 
turned off after 30 seconds of stimulation. Therefore 
the subjects felt the initial itching sensation, but 
received no current for the rest of the stimulation 
period. A recent study showed that this method of 
sham stimulation is reliable [17]. 
  Because we assumed that tDCS may act as a facilitator of 
behavioral modifications by establishing a favorable neural 
environment, all the stimulations were performed before the 
first hour of activities of the rehabilitation program. A 
constant current of 2 mA intensity was applied for 20 
minutes once a week for 10 weeks. The rationale for weekly 
frequency was the intention to couple stimulation with the 
activities of the multidisciplinary program and because daily 
stimulation would not be feasible. The device used for 
electric stimulation had a knob to allow the operator to 
control current intensity. Stimulation was ramped up or 
down in no more than 5 seconds. Stimulation with 2 mA (for 
a single session) has been shown to be safe in healthy 
volunteers [18]. 
Assessments 
  A blinded evaluator used the following instruments to 
score pain and quality of life in these patients immediately 
before and after the 4 month therapeutic program: 
  Visual analogue scale for pain (VAS) consists of a 100 
mm line with the expressions “no pain” and “worst pain” in 
each extremity. Subjects were requested to indicate the 
intensity of pain at the moment and that could be quantified 
in millimeters from the “no pain” extremity. 
  A dynamometer was used to determine the pressure 
threshold to elicit pain on the 18 fibromyalgia tender point - 
a mean value was recorded as “tenderness index”, which 
represented the mean pressure threshold to elicit pain [18]. 
  Brazilian versions of quality of life (QoL) questionnaires: 
•  Fibromyalgia Impact Questionnaire (FIQ) – which is 
a multidimensional instrument that measures 
functional capacity for daily living and work, as well 
as the sensation of well-being, pain, anxiety, 
depression, morning stiffness and sleep quality. Its 
final score varies from 0 (lowest impact or less deficit 
to functional capacity) to 100 (highest impact) [19]. Efficacy of Transcranial Direct Current Stimulation  The Open Rheumatology Journal, 2011, Volume 5   47 
•  SF-36 is a widely used QoL instrument which 
represents 8 generic health concepts: physical 
functioning, role-physical; bodily pain, general 
health, vitality, social functioning, role-emotional, 
and mental health – each of them is score from 0 
(worst) to 100 (best) [20]. 
•  Health Assessment Questionnaire (HAQ) disability 
index is directed to assess fine movements of the 
upper extremity, locomotor activities of the lower 
extremity, and activities that involve both the upper 
and lower extremities. Twenty questions on activities 
are distributed in 8 subscales, which are score in a 4 
level graduation. The summary score varies from 0 
(without any difficulty) to 3 (unable to do) [21]. 
•  Beck depression inventory (BDI) and Hamilton rating 
scale for depression (HAM) were used to evaluate 
severity of depression as mood changes is an 
important confounder [22]. 
Statistical Analysis 
  Having tested homogeneity of variances of the main 
outcomes, we performed a mixed ANOVA model in which 
we considered the subject as a random effect; condition of 
treatment and time of treatment as a fixed effect. We 
therefore included the following fixed effect variables in the 
model: time (pre and post-stimulation); condition of 
stimulation (tDCS/standard treatment vs sham tDCS/ 
standard treatment) and the interaction time*condition. 
  Unless stated otherwise, all results are presented as mean 
and standard deviation, and statistical significance refers to a 
two-tailed p value < 0.05. 
RESULTS 
  General characteristics of groups active and sham are 
shown in Table 1. Twelve patients were allocated to placebo 
stimulation and 11 to active stimulation, there were no 
patients lost to follow-up. It can be stated that subjects who 
received the active stimulation were older, had studied 
longer, their pain complaints lasted longer and were not 
economically active. Tricyclic antidepressants, selective 
serotonin reuptake inhibitors, muscle relaxants and 
paracetamol were equally used in both groups and there was 
no change in the use of such drugs with the treatment. 
Table  1.  General and Clinical Characteristic of Studied 
Subjects (Mean ± SD) 
 
 Active  Sham 
N 11  12 
Age (years)  58.3 ± 12.1  52.4 ± 11.5* 
Formal education (years)  6.3 ± 5.2  8.9 ± 4.4* 
Economically actives (%)  27.3  50* 
Duration of widespread pain (months)  9.9 ± 11.8  6.4 ± 10.2* 
* p<0,05. 
 
Pain Analysis 
  For pain, we analyzed two outcomes – current pain levels 
as assessed by VAS and the pain domain of SF-36. The 
advantage of using SF-36 is that pain in this scale is 
measured longitudinally, because it takes into account the 
last 4 weeks. Indeed, mixed ANOVA model for these two 
dependent variables showed no significant interaction effect 
for VAS (F(2,21)=0.4; p=0.67). Also, there was no 
statistically significant improvement in pressure tenderness 
until the end of the experiment in both groups, no interaction 
effect for dolorimetry was noticed (F(2,21)=0.8; p=0.54). 
However, for pain measured by SF-36, there was a 
significant interaction effect (F(2,21)=6.57; p=0.006). Post-
hoc tests showed that there was a significant reduction in 
pain after active tDCS/standard treatment (p=0.006); but not 
after sham tDCS/standard treatment (p=0.15) (see Fig. 1). 
Statistical significance could not be observed in the 
comparison of baseline mean values of VAS, SF-36 pain 
domain and pressure dolorimetry. 
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Fig. (1). SF-36 Pain domain scores (mean ± sd) before and after the 
intervention. 
Quality of Life 
  The secondary outcome of this study was quality of life 
and fatigue. For the remaining scores of SF-36 (all except for 
pain), the interaction term was not significant (F(2,21)=0.03; 
p=0.97); however for FIQ, there was a trend for a significant 
interaction term time by group (F(2,21)=2.43; p=0.11). We 
in an exploratory way, given that the interaction term was 
not significant, performed post-hoc comparisons for FIQ. 
Indeed there was a tendency for a significant decrease in FIQ 
scores after active tDCS/standard treatment (p=0.056), but 
not sham tDCS/standard treatment (p=0.18) (Fig. 2). 
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Fig. (2). FIQ scores (mean ± sd) before and after the intervention. 
Mood and Physical Disability 
  We finally performed the same analyses; but used mood 
scales (HDRS and BDI) and the disability assessment (as 48   The Open Rheumatology Journal, 2011, Volume 5  Riberto et al. 
indexed by HAQ) as the main outcomes. Although both 
groups showed marked significant improvement in physical 
capacity and mood (Table 2), further analyses showed a non-
significant interaction term (F(2,21)=1.42; p=0.31 for 
HDRS; F(2,21)=2.05; p=0.24 for BDI and F(2,21)=1.53; 
p=0.48 for HAQ); suggesting that active tDCS did not 
induce any additional beneficial effect on these domains 
compared with sham tDCS and multidisciplinary 
rehabilitation program. 
Table 2.  Means Scores (Mean ± SD) of HDRS, DBI and HAQ. 
 
 Inicial  Final p 
BDI  18.1 ± 11.2  14.0 ± 9.8  0.01 
HDRS  20.2 ± 8.5  16.1 ± 9.5  0.04 
HAQ  1.52 ± 0.47  1.26 ± 0.43  0.0005 
 
Correlations 
  For the two dependent variables that showed some 
association with the type of treatment – pain/SF-36 and FIQ; 
we performed correlations between scores changes in the 
active group vs demographic and clinical characteristics 
(baseline pain and fibromyalgia pressure points). There were 
no significant correlations; however moderate correlations 
between pain/SF-36 and age (r=0.53, p=0.09) and FIQ vs 
educational level (r=-0.52, p=0.097) were observed; such as 
that younger and more educated patients had a larger 
improvement. 
Blinding Evaluation 
  At the end of each tDCS session, patients had to answer 
if they think they received active or sham stimulation. The 
subjects in both groups guessed at chance level (sham 
stimulation: only 5/11 could guess correctly and active 
stimulation: only 5/12 could guess correctly). There were no 
significant differences across the two groups (p=0.72, 
Fisher’s exact test) 
DISCUSSION 
  Because of its multiple clinical manifestations, which 
range from musculoskeletal pain to complaints on other body 
systems and psychological disorders, multidisciplinary 
intervention has been recommended as the best approach for 
patients with fibromyalgia [23]. The rationale for this 
intervention is that a sum of small gains can result in a 
significant improvement in the global functioning of these 
patients. Among the most recommended activities is 
cardiovascular training [24], educative effort to support the 
understanding of the disease and pain controls strategies [25] 
and pharmacological interventions with tricyclic 
antidepressants, selective serotonin reuptake inhibitors [26] 
or  weak opiates [27]. The efficacy of multidisciplinary 
intervention to fibromyalgia has been demonstrated by 
different authors [23]. Due to the interference of pain in 
multiple aspects of functioning in these patients, composite 
instruments which involve dimensions such as pain, sleep 
quality, functional capacity and emotional status are 
recommended to evaluate the results of this intervention 
[28]. Parameters like HAQ, HDRS and BDI clearly 
improved, and FIQ showed a trend in the same direction, 
supporting the idea of global improvement in functional 
capacity, emotional aspects and reduction of the impact of 
fibromyalgia on functioning of these patients regardless the 
use of tDCS. These results on HAQ, HDRS and BDI reflect 
the beneficial effect of the multidisciplinary program both on 
psychological aspects and physical capacity, which result in 
an overall improvement of functioning. 
  Non-invasive brain stimulation has been proved to be 
effective for the reduction of pain in these patients in 
previous studies [9], so we tested whether noninvasive brain 
stimulation with tDCS could enhance the effects of the 
multidisciplinary program in pain reduction. The rationale 
for using tDCS to enhance this multidisciplinary program is 
based on the mechanisms of these two interventions [29]. 
The learning of new skills (in this case, reducing pain 
behaviors) is linked to changes in neuronal activity and 
excitability. They might reflect changes in synaptic strength, 
associated with long-term potentiation (LTP). Successful 
manipulation of cortical excitability to improve learning 
processes has been demonstrated in humans with tDCS [11]. 
TDCS presents an interesting alternative to these approaches, 
because it is non-invasive, painless and safe (compared to 
drugs). In addition, tDCS modifies spontaneous neuronal 
activity and therefore can increase activity in a more 
physiological manner and in addition be used while training 
is being performed [4]. Indeed several studies have shown 
that tDCS can increase cognitive gains when associated with 
behavioral interventions [4, 9-11]. 
  The association of tDCS to the multidisciplinary 
intervention did not prove to be effective in reducing pain as 
measured by the VAS. However, the evaluation of pain 
according to the pain domain of SF-36 showed significant 
reduction only in the group that received active stimulation. 
These differences may result from some points that need to 
be discussed. First, the instrument of evaluation. VAS 
measurement of pain is related to the perception during the 
patient assessment. In this context, SF-36 is a more 
appropriate scale as it evaluates the previous 4-week period. 
Also, not only does this later instrument inquire about the 
amount of pain over the body in the last 4 weeks, but also to 
which extent it interferes with social life. Because the focus 
of multidisciplinary intervention was directed to behaviors, 
and not only pain perception, an instrument with broader 
range of observation, like social life participation, is more 
appropriated. This idea is supported by the trend toward a 
significant better improvement in quality of life according to 
the FIQ, which is also a multidimensional tool. 
  Another important aspect is that we performed weekly, 
rather than daily, sessions of tDCS and this strategy might be 
less effective according to a recent study in stroke subjects 
[30], although this later study was directed to the treatment 
of depression, not pain. The rationale for weekly sessions 
was based on the fact that tDCS has shown to induce 
cumulative effects based on the findings of such use in 
chronic pain [8] and depression [30]. Therefore we 
hypothesized that stimulation once a week might induce 
cumulative effects. However the number of consecutive 
sessions to induce cumulative effects might be important as 
these studies used daily tDCS on weekdays for 10 sessions 
and showed some persistence of favorable outcomes on a 2 Efficacy of Transcranial Direct Current Stimulation  The Open Rheumatology Journal, 2011, Volume 5   49 
weeks follow-up. Stimulation of M1 was based firstly on the 
previous results of Fregni [9,14], who proved it to be more 
effective than prefrontal stimulation. Also, it is hypothesized 
that the thalamus, and therefore rostrocaudal pain inhibitory 
neural pathways are stimulated by afferences from M1, 
resulting in reduction of pain perception [31]. 
  Because improvement with active tDCS was observed 
only in one of the chosen outcomes, our results failed to fully 
support our hypothesis that weekly tDCS combined with a 
multidisciplinary approach is associated with beneficial 
effects for fibromyalgia. Therefore it is not clear whether this 
scenario with some significant findings and other lack of 
significant results is because our strategy of treatment 
(weekly rather than daily sessions), type of intervention 
(multidisciplinary approach) or instruments of evaluation. 
This question needs to be further explored in studies using 
other strategies of treatment. Alternatively, weekly anodal 
stimulation with tDCS over M1 may add no value over 
conventional rehabilitation for fibromyalgia. 
  Another critical issue for our mixed results is our small 
sample size that was based on positive results from a similar 
study, but that had a different context (daily tDCS sessions and 
no multidisciplinary treatment). Therefore it is possible that we 
were underpowered to detect a difference in the active vs sham 
groups in the other domains. Moreover, because both groups 
were under rehabilitation treatment, a reduction of effect size 
between stimulated and sham groups should be expected, 
requiring a larger sample to evidence the difference. However, 
we also considered that a significant difference with a larger 
population would not show a clinically meaningful result and in 
addition, in some of the tests, there was not even a trend for a 
significant result. Moreover, patient population was different as 
compared to Fregni’s study, in which patients did not undergo a 
simultaneous multidisciplinary approach [9,14], and therefore 
might also explain the differences. Although it can be said that 
to many variables were involved in the intervention, like drugs, 
tDCS and multidisciplinary approach, it is important to 
remember that our object was to check the efficacy of the 
association of interventions, rather than each of them isolated. 
Because fibromyalgia is a chronic condition, a follow-up 
assessment would be desired, but this was not planned in this 
study. Another limitation of this study is the fact that multiple 
comparisons were performed without corrections, like 
Bonferrogni, so there in a possibility that the few positive 
finding are only due to chance. Finally the results of this study 
should be viewed as exploratory as to design further studies on 
this field. 
CONCLUSION 
  This study could only partially show that tDCS may be 
an effective add-on treatment to a multidisciplinary approach 
in patients with fibromyalgia to reduce pain. Furthermore, a 
trend toward better global functioning was suggested 
regardless of tDCS. Future studies should test different 
protocols of stimulation with daily sessions of tDCS and also 
a maintenance treatment. 
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